In fact, a recent study demonstrated that the combination of globulin and albumin was able to predict outcome in GC patients undergoing curative surgery.6 Although the previous study mentioned that the combination of globulin and albumin stratified disease‐free survival (DFS) of GC patients with lymph node invasion or serosal invasion, and this combination was a good indication for postoperative adjuvant chemotherapy in such GC patients,6 the relationship between the GAR and tumor‐node‐metastasis (TNM) stage was unclear in that study. The gene discussed is ALB; the disease is neoplasm.